Skip to main content
Premium Trial:

Request an Annual Quote

Pall Acquires French Molecular Dx Firm

NEW YORK (GenomeWeb News) – Pall said today that it has acquired French molecular diagnostics firm GeneSystems for an undisclosed sum.
 
Bruz, France-based GeneSystems has developed a real-time PCR-based molecular diagnostics platform for rapid microbial detection. The firm offers tests for a range of pathogens including Legionella and E. coli.
 
Pall said the acquisition will expand its Total Fluid Management capabilities in the biopharmaceutical process monitoring market, which it estimated to be worth $1 billion. The East Hills, NY-based firm said that it also would provide it with new opportunities in the environmental, food and beverage, and water markets.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.